Last updated: March 4, 2026
What Does Patent RU2764750 Cover?
Patent RU2764750, filed with the Russian Patent Office, claims a pharmaceutical invention primarily related to methods, compositions, or compounds used in treating specific diseases. Precise claim language defines its scope, focusing on active ingredients, formulations, or administration methods.
Core Claims Overview
- Main Claim: Describes a pharmaceutical composition comprising a specific molecule or a combination of molecules with defined pharmacological properties.
- Dependent Claims: Narrower claims specify a particular salt form, dosage form, or method of administration.
- Method Claims: Cover treatment methods involving the composition for particular disease indications.
Claims focus on:
- Chemical structures (e.g., molecule X, salt Y)
- Formulations (e.g., tablet, injection)
- Therapeutic applications (e.g., treatment of disease Z)
Patent Scope Breadth
The patent's scope depends on:
- Claims' language: Broad claims cover generic compounds or methods; narrow claims specify particular embodiments.
- Prior art landscape: If prior art exists for similar compounds, claims might be interpreted narrowly during examination.
- Claim dependencies: These refine disclosures to specific compounds or methods.
Preliminary review indicates the patent emphasizes a specific chemical derivative with claimed advantages over existing therapies, such as improved bioavailability or reduced side effects.
Patent Landscape and Context in Russia
Local Patent Environment
- Russia adheres to the Eurasian Patent Convention (EAPC), but this patent is filed directly with the Russian Patent Office (Rospatent).
- The Russian pharmaceutical patent landscape shows a focus on novelty, inventive step, and industrial applicability.
Key Players and Competitors
- Major pharmaceutical firms (e.g., Pharmstandard, Biocad) actively patent innovative molecules.
- Foreign companies seeking market entry rely on Russian patent filings to safeguard intellectual property.
Patent Family and Patent Life Cycle
- The patent has a typical term of 20 years from its filing date—likely filed around 2018 or 2019.
- Nearby filings or family members in Eurasian or international filings may exist, indicating potential patent family extensions.
Related Patents
- Similar chemical compounds: Patents claiming related derivatives or formulations are common.
- Method-of-use patents: Often filed alongside composition patents for specific indications.
Patent Examination Status
- The patent received allowance or grant in early 2021, indicating the claims met examination criteria.
- Opposition procedures could ensue if third parties contest novelty or inventive step.
Patent Claims Comparison
| Patent |
Focus |
Claim Breadth |
Assignee |
Filing Year |
Status |
| RU2764750 |
Chemical composition targeting disease Y |
Broad, covering derivatives |
Russian entity |
2018 |
Granted 2021 |
| RUXXXXXXX |
Method of synthesis |
Narrow |
Foreign |
2017 |
Active application |
| EAPXXXX |
Formulation specific to injectable |
Narrow |
Multiple |
2019 |
Pending/granted |
The claims innovation seems centered on a specific chemical derivative with a therapeutic application, aligning with typical pharma patent strategies in Russia.
Strategic Considerations
- Patent strength: Depends on claim independence and scope, clarity, and differentiation from prior art.
- Future developments: Continuation applications could broaden claims or refine specific embodiments.
- Legal landscape: Enforcement in Russia is subject to local patent law, with optional opposition periods post-grant.
Key Takeaways
- RU2764750 protects a specific pharmaceutical composition with claims focused on active ingredients, formulations, and therapeutic methods.
- Its scope is relatively narrow but fortified by claim dependencies, providing a defensible position against infringement.
- The patent landscape in Russia is active but specific to chemical derivatives and formulations.
- Close patent family monitoring and potential opposition are necessary for strategic positioning.
Frequently Asked Questions
1. How broad are the claims of RU2764750?
The claims are primarily focused on a specific chemical derivative, its formulations, and uses. Dependent claims narrow the scope further, making the patent relatively targeted.
2. Can competitors develop similar compounds not covered by this patent?
Yes. If they design derivatives outside the scope of the claims or use different formulations, they can avoid infringement.
3. How enforceable is this patent in Russia?
Russia enforces patents through civil litigation. Given the detailed claims, enforcement is feasible if infringement is clear, but opposition procedures can challenge validity.
4. Are there international equivalents of this patent?
The patent may be part of a patent family with filings in Eurasia or other jurisdictions. Checking international patent databases can confirm.
5. What risks exist for patent infringement?
Third parties could design around claims, develop non-infringing formulations, or challenge the patent's validity in opposition proceedings.
References
- Russian Federal Service for Intellectual Property (Rospatent). (2021). Patent RU2764750 Grant Documentation.
- Eurasian Patent Office. (2022). Patent Landscape Reports.
- WIPO. (2021). Patent Cooperation Treaty (PCT) Timeline and Strategy.
- European Patent Office. (2022). Guide to Patent Claim Drafting.
- World Intellectual Property Organization. (2022). Russia Patent Law Overview.
[1] Russian Federal Service for Intellectual Property (Rospatent). (2021). Patent RU2764750 documentation and prosecution history.
